Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xarelto (Rivaroxaban) Risk Minimisation Plan Evaluation: Patient and Physician Knowledge of Key Safety Messages

NCT01907048 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01907048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01907048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xarelto (Rivaroxaban) Risk Minimisation Plan Evaluation: Patient and Physician Knowledge of Key Safety Messages
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
September 15, 2014
Completion date
April 15, 2020
Enrollment
2,227 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulation